Literature DB >> 19184605

The role of transthoracic echocardiography in embolic acute limb ischaemia.

A Lewis1, G Kirk, A McKinley, P H Blair, D W Harkin.   

Abstract

INTRODUCTION: Embolic acute limb ischaemia (ALI) is commonly treated by re-vascularization and long-term anticoagulant therapy. Transthoracic echocardiography (TTE) is commonly used to screen for cardiac embolic source, but may not affect management. REPORT: We reviewed 115 consecutive patients with embolic ALI, 61% underwent TTE, with cardiac thrombus identified in only 3%. Incidental severe abnormalities requiring further cardiological investigation were detected in 19% of patients. Inpatient TTE did not affect mortality, morbidity, amputation rate, or anticoagulation. DISCUSSION: Transthoracic echocardiography seldom identifies a cardiac embolic source, but identifies many patients with severe incidental cardiac abnormalities, suggesting cardiology screening of these patients remains important.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184605     DOI: 10.1007/s11845-009-0284-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

Review 1.  ABC of arterial and venous disease: Acute limb ischaemia.

Authors:  K Callum; A Bradbury
Journal:  BMJ       Date:  2000-03-18

2.  Operative mortality and long-term survival of patients operated on for acute lower limb ischaemia.

Authors:  S Aune; A Trippestad
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-02       Impact factor: 7.069

Review 3.  Echocardiography in the evaluation of cardiac sources of emboli: the role of transthoracic echocardiography.

Authors:  R W Asinger; C A Herzog; C D Dick
Journal:  Echocardiography       Date:  1993-07       Impact factor: 1.724

Review 4.  Transthoracic echocardiography versus transesophageal echocardiography in detecting cardiac sources of embolism.

Authors:  A C Pearson
Journal:  Echocardiography       Date:  1993-07       Impact factor: 1.724

5.  Morbidity and mortality in acute lower limb ischaemia: a 5-year review.

Authors:  A E Clason; P A Stonebridge; A J Duncan; B Nolan; A M Jenkins; C V Ruckley
Journal:  Eur J Vasc Surg       Date:  1989-08

6.  Acute ischaemia of the lower limb: the effect of centralizing vascular surgical services on morbidity and mortality.

Authors:  A E Clason; P A Stonebridge; A J Duncan; B Nolan; A M Jenkins; C V Ruckley
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

7.  Vascular surgical society of great britain and ireland: two-year follow-up after acute thromboembolic lower limb ischaemia: the importance of continuing warfarin treatment

Authors: 
Journal:  Br J Surg       Date:  1999-05       Impact factor: 6.939

8.  Is long-term anticoagulation after acute thromboembolic limb ischemia always necessary?

Authors:  Thomas L Forbes; Guy DeRose; Kenneth A Harris
Journal:  Can J Surg       Date:  2002-10       Impact factor: 2.089

9.  Peripheral arterial embolism: prevalence, outcome, and the role of echocardiography in management.

Authors:  J A Gossage; T Ali; J Chambers; K G Burnand
Journal:  Vasc Endovascular Surg       Date:  2006 Aug-Sep       Impact factor: 1.089

10.  Perioperative outcome of acute lower limb ischaemia on the basis of the national vascular registry. The Finnvasc Study Group.

Authors:  P Kuukasjärvi; J P Salenius
Journal:  Eur J Vasc Surg       Date:  1994-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.